FDA Adverse Event Injury Summary report: N

CARPENTIER-EDWARDS PERIMOUNT AORTIC PERICARDIAL BIOPROSTHESIS

MDR report key: 1509946 · Received October 19, 2009

Report

Report Number
2015691-2009-11857
Event Type
Injury
Date Received
October 19, 2009
Date of Event
June 4, 2009
Report Date
September 24, 2009
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
P860057
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORD (DHR) REVIEW WAS COMPLETED, AND THIS DEVICE PASSED ALL MANUFACTURING AND STERILIZATION INSPECTIONS WITH NO NONCONFORMANCE.

Additional Manufacturer Narrative · 1

THIS EVENT WAS DETERMINED TO BE REPORTABLE PER EDWARDS LIFESCIENCES PROCEDURES. THE INFORMATION WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY. A DEVICE HISTORY RECORD REVIEW IS IN PROCESS. TWO REQUESTS WERE MADE (VIA FAX) FOR THE DEVICE, OPERATIVE REPORT, AND ADDITIONAL INFORMATION, HOWEVER, NO ADDITIONAL INFORMATION WAS PROVIDED, AND NO DEVICE WAS RETURNED FOR EVALUATION.

Description of Event or Problem · 1

PATIENT #4 FROM LITERATURE: L.G. CLOSE, A.K. HSU, S. RICKERT, M. SHRIME, A. TABAEE (2006). SYNECHIA FORMATION AFTER ENDOSCOPIC SINUS SURGERY AND MIDDLE TURBINATE MEDIALIZATION WITH AND WITHOUT FLOSEAL. AMERICAN JOURNAL OF RHINOLOGY(2007) 21:174-179. SUMMARY OF ARTICLE FROM ABSTRACT: THIRTY-SEVEN PATIENTS UNDERWENT MEDIALIZATION WITH PLACEMENT OF FLOSEAL. A STATISTICALLY SIGNIFICANT HIGHER INCIDENCE OF SYNECHIA FORMATION WAS NOTED IN PATIENTS WHO UNDERWENT MIDDLE TURBINATE MEDIALIZATION WITH THE PLACEMENT OF FLOSEAL (18.9%).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE DEVICE WAS EXPLANTED AFTER A IMPLANT DURATION OF 119 MONTHS, DUE TO UNKNOWN REASONS. NO FURTHER DETAILS WERE PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CARPENTIER-EDWARDS PERIMOUNT AORTIC PERICARDIAL BIOPROSTHESIS REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES 2700 8K1330

Patients

Seq Age Sex Outcome Treatment
1 32 YR Required Intervention